Interventional device firm Guidant said it has received CE Mark approval for Multi-Link Mini Vision, the company's cobalt chromium stent designed for treating coronary artery disease in small vessels. Guidant's Voyager coronary dilatation catheter has also been approved.
Multi-Link Mini Vision is available in a wide range of sizes in Europe, the Middle East, Australia, and New Zealand. Indianapolis-based Guidant expects to launch the stents in the U.S. and other regions later this year.
Voyager RX will launch immediately in Europe, and the devices will be introduced in Asia, the Middle East, and Latin America shortly thereafter. Guidant said it anticipates FDA approval for the product later this year.
By AuntMinnie.com staff writersMay 27, 2004
Related Reading
Dollens to retire from Guidant helm, May 18, 2004
Guidant notches record Q1, April 22, 2004
Guidant completes BVS acquisition, April 21, 2004
Guidant reports preliminary Q1 sales of nearly $1 billion, April 7, 2004
Guidant completes stent trial enrollment, April 1, 2004
Copyright © 2004 AuntMinnie.com
